Product
Recombinant Human Follicle Stimulating Hormone
1 clinical trial
1 indication
Indication
InfertilityClinical trial
A Randomized, Parallel-group, Multi-Center, Assessor-blind Phase 3 Study to Compare the Efficacy, Safety and Ease of Use of Two Follicle Stimulating Hormone -Human Recombinant (r-hFSH) 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen (Foligraf®- Manufactured by BSV and Gonal-f® Manufactured by Merck Serono) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive TechnologyStatus: Active (not recruiting), Estimated PCD: 2023-08-31